Category: Endoscopic / Arthroscopic

SurgiQuest drums up $14.5 million

February 16, 2010 by MassDevice staff

SurgiQuest Inc. drummed up $14.5 million in new backing from 11 un-named investors, according to a regulatory filing.

The Orange, Conn.-based device maker is developing technology for laparoscopic procedures that's designed remove electrosurgical smoke and keep endoscopic imaging instruments' field of vision clear. While the filing did not reveal the identities of SurgiQuest's latest backers, two members of its board of directors listed on the document also represent venture capital firms: Rodney Altman of CMEA Ventures and Ned Scheetz of Aphelion Capital LLC.

Vision-Sciences posts lower Q3 sales, losses widen 6 percent

February 12, 2010 by MassDevice staff

Vision-Sciences Inc. (NSDQ:VSCI) posted third-quarter sales of $2.6 million for the three months ended Dec. 31, 2009, down 28 percent compared with $3.6 million during the same period in 2008. Net losses widened 5.6 percent to $3.2 million, compared with $3.1 million during Q3 2008:

Medtronic touts endoscopy sheath study

February 5, 2010 by MedCity News

By Brandon Glenn

MINNEAPOLIS, Minnesota — A new study suggests that sterile sheaths are as effective in preventing contamination of endoscopes as the traditional method of soaking the instruments in germicidal liquid, device giant Medtronic Inc. (NYSE:MDT) said.

ConMed swings from red to black despite Q4 sales slide

February 4, 2010 by MassDevice staff

ConMed Corp. (NSDQ:CNMD) posted fourth-quarter sales of $179.2 million for the three months ended Dec. 31, 2009, down 6 percent compared with $190.6 million during the same period in 2008. Net income rose 67.9 percent to $8.3 million, compared with $5 million during Q4 2008:

Press Release

CONMED Corporation Announces Fourth Quarter and Full Year 2009 Results

Fourth Quarter Sales Increase 6.4%

Solos Endoscopy reports Q4 sales rise 9 percent over the prior quarter

January 22, 2010 by MassDevice staff

Solos Endoscopy Inc. (OTC:SNDY) reported $125,791 in fourth-quarter sales, a 9.2 percent uptick compared with its third-quarter sales.

The Boston-based company, which makes endoscopic instruments and imaging equipment, said the increase over the $115,159 worth of sales transactions it posted during Q3 2009 was consistent with its full-year results.

UPDATE: Hologic loses patent fight to SenoRx, plans appeal

December 21, 2009 by MassDevice staff

Hologic Inc. (NSDQ:HOLX) lost a patent battle with SenoRx Inc. (NSDQ:SENO), after a California jury ruled a pair of Hologic patents invalid.

In a lawsuit filed late last year, Bedford, Mass.-based Hologic accused SenoRx of infringing two patents covering Hologic's MammoSite breast cancer radiation therapy system with its Contura device. But a jury in the U.S. District Court for Northern California decided that both patents were invalid and that, in any case, Aliso Viejo, Calif.-based SenoRx didn't violate one of them.

Hologic said it plans to appeal the decision to the Court of Appeals for the Federal Circuit.